In the studied series, the expression of FOXA1 was inversely associated with clinicopathological features – namely, with tumour size, tumour grade, Nottingham Prognostic Index, lymph vascular invasion, lymph node stage and HER-2 overexpression – while its expression was directly associated with ERα, PR and the luminal A subtype. This evidence concerns the gene PGR and neoplasm.